IndraLab

Statements

Vascular Diseases inhibits BRCC3. 1 / 1

| 1

reach

"For the treatment of vascular diseases, silencing of ncRNAs provides potential therapeutic strategies by inducing ubiquitination degradation (miR-29a, miR-181b, lncRNA-Fendrr, lncRNA MIAT, lncRNA SNHG, miR-21, miR-424(322)) or inhibiting the deubiquitinating enzyme BRCC3/SUMO1 (lncRNA NEAT1, lncRNA SOX2-OT) (73, 82, 93, 96, 98, 100, 110, 111, 116)."

38515760

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

Vascular Diseases inhibits BRCC3. 1 / 1

INDRA sources:

Databases

Reading